Assignee
INTOCELL INC
KR·8 granted patents·5 pending applications·6 citations·filing 2017–2024
Top patents by PatentIndex Score
13 records- 0183US11807628B2Benzodiazepine derivatives and uses thereofINTOCELL INC·Filed 2021·Granted Nov 7, 2023·1 cites·20 claims
- 0283US11065343B2Compound bearing beta-galactoside-introduced self-immolative linkerINTOCELL INC·Filed 2017·Granted Jul 20, 2021·3 cites·14 claims
- 0375US11084801B2Benzodiazepine derivatives and uses thereofINTOCELL INC·Filed 2019·Granted Aug 10, 2021·1 cites·10 claims
- 0473US11753431B2Compounds comprising cleavable linker and uses thereofINTOCELL INC·Filed 2018·Granted Sep 12, 2023·1 cites·20 claims
- 0570US12479927B2Compounds comprising cleavable linker and uses thereofINTOCELL INC·Filed 2023·Granted Nov 25, 2025·0 cites·15 claims
- 0670US2025121087A1Antibody-drug conjugates comprising anti-b7-h3 antibodiesINTOCELL INC·Filed 2024·Application pending·0 cites
- 0763US2025213712A1Antibody drug conjugates comprising camptothecin derivatives and uses thereofINTOCELL INC·Filed 2024·Application pending·0 cites
- 0859US12168060B2Antibody-drug conjugates comprising anti-B7-H3 antibodiesINTOCELL INC·Filed 2021·Granted Dec 17, 2024·0 cites·22 claims
- 0956US2023190939A1Antibody drug conjugates comprising toxins with polar groups and uses thereofINTOCELL INC·Filed 2022·Application pending·0 cites
- 1046US12274898B2Substituted benzodiazepines as antibody-drug conjugatesINTOCELL INC·Filed 2019·Granted Apr 15, 2025·0 cites·19 claims
- 1146US2023039858A1Compositions and methods related to molecular conjugationINTOCELL INC·Filed 2020·Application pending·0 cites
- 1244US12551570B2Compounds comprising cleavable linker and uses thereofINTOCELL INC·Filed 2020·Granted Feb 17, 2026·0 cites·21 claims
- 1344US2022118104A1Compounds comprising cleavable linker and uses thereofINTOCELL INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →